SlideShare a Scribd company logo
Medicines Optimisation
Richard Harris MRPharmS
21/11/2016
1
Medicines Optimisation Aim
Identification, Intervention and Resolution of
adverse medicines performance, inappropriate
prescribing and compliance issues
 Improve Treatment Outcomes for Patients
 Improve value for money for the wider NHS
 Improve quality, safety & optimal treatment
outcomes based on best evidence
 Patient Engagement
21/11/2016
2
Clinical Screen
(Identify)
Best Practice
(Plan)
Medicine
Optimisation
(Action)
Review
Outcomes
(Evaluate)
Patient
3
21/11/2016
4
How Can Pharmacists Contribute ?
 Ensure safe prescribing & administration of medication that adheres to
best evidence & practice
 Cost effective-QIPP drop lists -drugs of limited clinical value
 Assess Drug History & Monitor for Polypharmacy/ prescribing cascades
& ADEs-Document-Communicate-Challenge
 Optimise Drug Therapy- Switching/ patent expiry
 Medicines waste campaigns e.g. patient education awareness
 Medicines Optimisation Training (MDT/GP Practices/ Care Homes)
 Provide co-ordinated medicine information to patients/carers/relatives
as part of the discharge-planning process
21/11/2016
5
Case study - Elsie 78
• Recently discharged from hospital after a fall
• She lives alone
• Elsie says her mobility and eye sight are getting worse.
• Takes Furosemide 40mg BD –doesn’t like ‘water tablet’
• Recently prescribed Nitrazepam to help poor sleep.
• Reports feeling thirsty
What Are The Risk Factors?
• Age
• Falls history
• Adherence concerns-cognitive/physical
• New medication
• Undiagnosed disease?
• Isolation
Supporting Medicines Optimisation & reduce further falls
• Is diuretic suitable? Consider recommending an alternative
• Switch to a shorter acting benzodiazepine e.g. Zopiclone - consider cessation
• Increased thirst may suggests undiagnosed diabetes-referral
• Is Elsie managing to take her tablets OK on her own?- Ask the patient-check her
medicines with her-advise on correct use - consider compliance aid
• Wider question over independence : Engage with MDT/arrange care package
21/11/2016
6
Case Study : Omega 3 Low Priority Poor Value
The NHS Midlands and East spent £2.5 million on omega-3 fatty acids compounds in 2012-2013
Source: PrescQIPP Bulletin 47 October 2013
NICE Guideline-Evidence base
PrescQIPP Drop List
Letter of Advice/PIL to Patient
Agree protocol/process
Audit practice/patients
Monitor savings -
summary report
Omacor
I capsule daily =
28 day saving of
£14.28
Medicine Stopped
Pharmacist CCG
Medicines Review
Optimisation
21/11/2016
7
•Prioritise:
• Engage the patient in the process
•Aim:
• Keep regimes as simple as possible-reduce pill burden
•Modify:
• Make recommendations including cessation- “is the drug still
needed?”
•Prevent :
• Adherence issues-check patient understanding, Identify & resolve
barriers, explain & monitor changes
Presentation Summary
Any Questions?
8
Thank You

More Related Content

What's hot

Wardround documentation audit
Wardround documentation auditWardround documentation audit
Wardround documentation audit
Conrad Lee
 
Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015
NHS England
 
Patient councilling
Patient councillingPatient councilling
Patient councilling
PARUL UNIVERSITY
 
Medication Adherence Measure Update and Goals
Medication Adherence Measure Update and GoalsMedication Adherence Measure Update and Goals
Medication Adherence Measure Update and Goals
Marion Sills
 
ASE_C_POP APSA poster final
ASE_C_POP APSA poster finalASE_C_POP APSA poster final
ASE_C_POP APSA poster final
Tony Hall
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
Khadga Raj
 
Clinical pathways
Clinical pathwaysClinical pathways
Clinical pathways
Ihsan ullah khamoosh
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
Emani Aparna
 
The Evolution and Outcomes of Pharmacist Medication History Services
The Evolution and Outcomes of Pharmacist Medication History ServicesThe Evolution and Outcomes of Pharmacist Medication History Services
The Evolution and Outcomes of Pharmacist Medication History Services
Allina Health
 
Patient data analysis
Patient data analysisPatient data analysis
Patient data analysis
Rafi Bhat
 
adherence
adherenceadherence
adherence
IAU Dent
 
Pharmacy Interventions - For Next generation patient engagement
Pharmacy Interventions - For Next generation patient engagement Pharmacy Interventions - For Next generation patient engagement
Pharmacy Interventions - For Next generation patient engagement
Multiple Startups
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
velspharmd
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
Sarah Pulackal
 
Medication adherence,
Medication adherence,Medication adherence,
Medication adherence,
AswathySachidanandan
 
Patient compliance
Patient compliancePatient compliance
Patient compliance
vikasaagrahari007
 
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
Naz Usmani
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
Subhash Yende
 
Medication history
Medication historyMedication history
Medication history
Nursing Hi Nursing
 
Nick_Jeanne_VTE_FishBone
Nick_Jeanne_VTE_FishBoneNick_Jeanne_VTE_FishBone
Nick_Jeanne_VTE_FishBone
Nicholas Thomson
 

What's hot (20)

Wardround documentation audit
Wardround documentation auditWardround documentation audit
Wardround documentation audit
 
Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015Medicines optimisation, pop up uni, 9am, 3 september 2015
Medicines optimisation, pop up uni, 9am, 3 september 2015
 
Patient councilling
Patient councillingPatient councilling
Patient councilling
 
Medication Adherence Measure Update and Goals
Medication Adherence Measure Update and GoalsMedication Adherence Measure Update and Goals
Medication Adherence Measure Update and Goals
 
ASE_C_POP APSA poster final
ASE_C_POP APSA poster finalASE_C_POP APSA poster final
ASE_C_POP APSA poster final
 
Medication history interview
Medication history interviewMedication history interview
Medication history interview
 
Clinical pathways
Clinical pathwaysClinical pathways
Clinical pathways
 
New microsoft office power point presentation
New microsoft office power point presentationNew microsoft office power point presentation
New microsoft office power point presentation
 
The Evolution and Outcomes of Pharmacist Medication History Services
The Evolution and Outcomes of Pharmacist Medication History ServicesThe Evolution and Outcomes of Pharmacist Medication History Services
The Evolution and Outcomes of Pharmacist Medication History Services
 
Patient data analysis
Patient data analysisPatient data analysis
Patient data analysis
 
adherence
adherenceadherence
adherence
 
Pharmacy Interventions - For Next generation patient engagement
Pharmacy Interventions - For Next generation patient engagement Pharmacy Interventions - For Next generation patient engagement
Pharmacy Interventions - For Next generation patient engagement
 
Clinical pharmacy services
Clinical pharmacy servicesClinical pharmacy services
Clinical pharmacy services
 
Pharmaceutical care
Pharmaceutical carePharmaceutical care
Pharmaceutical care
 
Medication adherence,
Medication adherence,Medication adherence,
Medication adherence,
 
Patient compliance
Patient compliancePatient compliance
Patient compliance
 
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
Standard of care / Standard of Practice / Clinical Guideline/ Clinical Pathway
 
Patients medication history interview
Patients medication history interviewPatients medication history interview
Patients medication history interview
 
Medication history
Medication historyMedication history
Medication history
 
Nick_Jeanne_VTE_FishBone
Nick_Jeanne_VTE_FishBoneNick_Jeanne_VTE_FishBone
Nick_Jeanne_VTE_FishBone
 

Viewers also liked

Practica integradora ii parcial administracion de un sistema operativo comer...
Practica integradora ii parcial  administracion de un sistema operativo comer...Practica integradora ii parcial  administracion de un sistema operativo comer...
Practica integradora ii parcial administracion de un sistema operativo comer...
Angel Rene
 
Bullying
BullyingBullying
Instrumentosevaluacion
InstrumentosevaluacionInstrumentosevaluacion
Instrumentosevaluacion
javiuclm4
 
Necesidades y motivaciones
Necesidades y motivacionesNecesidades y motivaciones
Necesidades y motivaciones
lucero1998
 
FinalThesis
FinalThesisFinalThesis
FinalThesis
Tom Triffitt
 
Kontinuitet & förändring
Kontinuitet & förändringKontinuitet & förändring
Kontinuitet & förändring
Adam Bergholm
 
план вивчення теми.Doc
план вивчення теми.Docплан вивчення теми.Doc
план вивчення теми.Doc
MalaOlga
 
Velo Write Up
Velo Write UpVelo Write Up
Velo Write Up
Nathaniel Baird
 
RESUME
RESUMERESUME

Viewers also liked (10)

Practica integradora ii parcial administracion de un sistema operativo comer...
Practica integradora ii parcial  administracion de un sistema operativo comer...Practica integradora ii parcial  administracion de un sistema operativo comer...
Practica integradora ii parcial administracion de un sistema operativo comer...
 
Bullying
BullyingBullying
Bullying
 
Instrumentosevaluacion
InstrumentosevaluacionInstrumentosevaluacion
Instrumentosevaluacion
 
Necesidades y motivaciones
Necesidades y motivacionesNecesidades y motivaciones
Necesidades y motivaciones
 
FinalThesis
FinalThesisFinalThesis
FinalThesis
 
Kontinuitet & förändring
Kontinuitet & förändringKontinuitet & förändring
Kontinuitet & förändring
 
план вивчення теми.Doc
план вивчення теми.Docплан вивчення теми.Doc
план вивчення теми.Doc
 
Velo Write Up
Velo Write UpVelo Write Up
Velo Write Up
 
атеросклероз
атеросклерозатеросклероз
атеросклероз
 
RESUME
RESUMERESUME
RESUME
 

Similar to Oxford medicines optimisation presentation

Mitigating Risk When Managing High Dose, Chronic Pain Patients
Mitigating Risk When Managing High Dose, Chronic Pain Patients Mitigating Risk When Managing High Dose, Chronic Pain Patients
Mitigating Risk When Managing High Dose, Chronic Pain Patients
Polsinelli PC
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
rishi2789
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptx
MansoorKhan22677
 
Drug utilization review 1
Drug utilization review 1Drug utilization review 1
Drug utilization review 1
Kainat Fatima
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
National Ovarian Cancer Coalition
 
Audit of Care Home Medication Reviews .pdf
Audit of Care Home Medication Reviews .pdfAudit of Care Home Medication Reviews .pdf
Audit of Care Home Medication Reviews .pdf
Health Innovation Wessex
 
PHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docxPHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docx
NbkKarim1
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
MuungoLungwani
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
raviapr7
 
How to work in partnership with the LPP
How to work in partnership with the LPPHow to work in partnership with the LPP
How to work in partnership with the LPP
PM Society
 
Lecture one: Patient Assessment in Pharmacy Practice
Lecture one: Patient Assessment in Pharmacy PracticeLecture one: Patient Assessment in Pharmacy Practice
Lecture one: Patient Assessment in Pharmacy Practice
Anas Bahnassi أنس البهنسي
 
DUR and DUE.ppt
DUR and DUE.pptDUR and DUE.ppt
DUR and DUE.ppt
UVAS
 
Comprehensive and person centred approach to addressing Polypharmacy in adult...
Comprehensive and person centred approach to addressing Polypharmacy in adult...Comprehensive and person centred approach to addressing Polypharmacy in adult...
Comprehensive and person centred approach to addressing Polypharmacy in adult...
Health Innovation Wessex
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
UVAS
 
Clinical edvidence and access for medicinal cannabis products
Clinical edvidence and access for medicinal cannabis productsClinical edvidence and access for medicinal cannabis products
Clinical edvidence and access for medicinal cannabis products
TGA Australia
 
Clinical pharmacy ppt
Clinical pharmacy pptClinical pharmacy ppt
Clinical pharmacy ppt
Nabi Hasan
 
Patient compliance Pdf
Patient compliance PdfPatient compliance Pdf
Patient compliance Pdf
Asraful Islam Rayhan
 
Rare disease stakeholder dynamics pmrg institute fall 2014
Rare disease stakeholder dynamics  pmrg institute fall 2014Rare disease stakeholder dynamics  pmrg institute fall 2014
Rare disease stakeholder dynamics pmrg institute fall 2014
azdybak
 
Good Pharmacy Practice.ppt
Good Pharmacy Practice.pptGood Pharmacy Practice.ppt
Good Pharmacy Practice.ppt
SanjeevPandey284481
 
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmcccccccGood Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Sanjiv Pandey
 

Similar to Oxford medicines optimisation presentation (20)

Mitigating Risk When Managing High Dose, Chronic Pain Patients
Mitigating Risk When Managing High Dose, Chronic Pain Patients Mitigating Risk When Managing High Dose, Chronic Pain Patients
Mitigating Risk When Managing High Dose, Chronic Pain Patients
 
RDP-CP-PP.pdf
RDP-CP-PP.pdfRDP-CP-PP.pdf
RDP-CP-PP.pdf
 
patient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptxpatient care with Types of Pharmaceutical Care 2.pptx
patient care with Types of Pharmaceutical Care 2.pptx
 
Drug utilization review 1
Drug utilization review 1Drug utilization review 1
Drug utilization review 1
 
NCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian CancerNCCN Guidelines for Patients: Ovarian Cancer
NCCN Guidelines for Patients: Ovarian Cancer
 
Audit of Care Home Medication Reviews .pdf
Audit of Care Home Medication Reviews .pdfAudit of Care Home Medication Reviews .pdf
Audit of Care Home Medication Reviews .pdf
 
PHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docxPHARMACEUTICAL CARE.docx
PHARMACEUTICAL CARE.docx
 
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
PMY 6120_1-2-Pharmaceutical Formulation Systems_Compound and Dispensing Proce...
 
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptxClinical Pharmacy  Introduction to Clinical Pharmacy, Concept of clinical pptx
Clinical Pharmacy Introduction to Clinical Pharmacy, Concept of clinical pptx
 
How to work in partnership with the LPP
How to work in partnership with the LPPHow to work in partnership with the LPP
How to work in partnership with the LPP
 
Lecture one: Patient Assessment in Pharmacy Practice
Lecture one: Patient Assessment in Pharmacy PracticeLecture one: Patient Assessment in Pharmacy Practice
Lecture one: Patient Assessment in Pharmacy Practice
 
DUR and DUE.ppt
DUR and DUE.pptDUR and DUE.ppt
DUR and DUE.ppt
 
Comprehensive and person centred approach to addressing Polypharmacy in adult...
Comprehensive and person centred approach to addressing Polypharmacy in adult...Comprehensive and person centred approach to addressing Polypharmacy in adult...
Comprehensive and person centred approach to addressing Polypharmacy in adult...
 
Pharmacy practice.pdf
Pharmacy practice.pdfPharmacy practice.pdf
Pharmacy practice.pdf
 
Clinical edvidence and access for medicinal cannabis products
Clinical edvidence and access for medicinal cannabis productsClinical edvidence and access for medicinal cannabis products
Clinical edvidence and access for medicinal cannabis products
 
Clinical pharmacy ppt
Clinical pharmacy pptClinical pharmacy ppt
Clinical pharmacy ppt
 
Patient compliance Pdf
Patient compliance PdfPatient compliance Pdf
Patient compliance Pdf
 
Rare disease stakeholder dynamics pmrg institute fall 2014
Rare disease stakeholder dynamics  pmrg institute fall 2014Rare disease stakeholder dynamics  pmrg institute fall 2014
Rare disease stakeholder dynamics pmrg institute fall 2014
 
Good Pharmacy Practice.ppt
Good Pharmacy Practice.pptGood Pharmacy Practice.ppt
Good Pharmacy Practice.ppt
 
Good Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmcccccccGood Pharmacy Practice.pptccccccmmmmmmccccccc
Good Pharmacy Practice.pptccccccmmmmmmccccccc
 

More from Richard Harris

Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
Richard Harris
 
St Andrews Presentation.
St Andrews Presentation.St Andrews Presentation.
St Andrews Presentation.
Richard Harris
 
Black Country Partnership Trust Presentation (1)
Black Country Partnership Trust Presentation (1)Black Country Partnership Trust Presentation (1)
Black Country Partnership Trust Presentation (1)
Richard Harris
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
Richard Harris
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
Richard Harris
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
Richard Harris
 

More from Richard Harris (6)

Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
 
St Andrews Presentation.
St Andrews Presentation.St Andrews Presentation.
St Andrews Presentation.
 
Black Country Partnership Trust Presentation (1)
Black Country Partnership Trust Presentation (1)Black Country Partnership Trust Presentation (1)
Black Country Partnership Trust Presentation (1)
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
 
Falls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacistFalls prevention and the role of the pharmacist
Falls prevention and the role of the pharmacist
 

Recently uploaded

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
Jim Jacob Roy
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
Holistified Wellness
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
shivalingatalekar1
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
reignlana06
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
Dr. Jyothirmai Paindla
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
rishi2789
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
rishi2789
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
AyeshaZaid1
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
19various
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
MedicoseAcademics
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
Gokuldas Hospital
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
Pratik328635
 

Recently uploaded (20)

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Acute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdfAcute Gout Care & Urate Lowering Therapy .pdf
Acute Gout Care & Urate Lowering Therapy .pdf
 
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
8 Surprising Reasons To Meditate 40 Minutes A Day That Can Change Your Life.pptx
 
Cardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdfCardiac Assessment for B.sc Nursing Student.pdf
Cardiac Assessment for B.sc Nursing Student.pdf
 
Adhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.comAdhd Medication Shortage Uk - trinexpharmacy.com
Adhd Medication Shortage Uk - trinexpharmacy.com
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
Efficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in AyurvedaEfficacy of Avartana Sneha in Ayurveda
Efficacy of Avartana Sneha in Ayurveda
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdfCHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
CHEMOTHERAPY_RDP_CHAPTER 6_Anti Malarial Drugs.pdf
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 1_ANTI TB DRUGS.pdf
 
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptxMuscles of Mastication by Dr. Rabia Inam Gandapore.pptx
Muscles of Mastication by Dr. Rabia Inam Gandapore.pptx
 
Histololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptxHistololgy of Female Reproductive System.pptx
Histololgy of Female Reproductive System.pptx
 
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa CentralClinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
Clinic ^%[+27633867063*Abortion Pills For Sale In Tembisa Central
 
The Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of RespirationThe Nervous and Chemical Regulation of Respiration
The Nervous and Chemical Regulation of Respiration
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.How to choose the best dermatologists in Indore.
How to choose the best dermatologists in Indore.
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Outbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptxOutbreak management including quarantine, isolation, contact.pptx
Outbreak management including quarantine, isolation, contact.pptx
 

Oxford medicines optimisation presentation

  • 2. Medicines Optimisation Aim Identification, Intervention and Resolution of adverse medicines performance, inappropriate prescribing and compliance issues  Improve Treatment Outcomes for Patients  Improve value for money for the wider NHS  Improve quality, safety & optimal treatment outcomes based on best evidence  Patient Engagement 21/11/2016 2
  • 4. 21/11/2016 4 How Can Pharmacists Contribute ?  Ensure safe prescribing & administration of medication that adheres to best evidence & practice  Cost effective-QIPP drop lists -drugs of limited clinical value  Assess Drug History & Monitor for Polypharmacy/ prescribing cascades & ADEs-Document-Communicate-Challenge  Optimise Drug Therapy- Switching/ patent expiry  Medicines waste campaigns e.g. patient education awareness  Medicines Optimisation Training (MDT/GP Practices/ Care Homes)  Provide co-ordinated medicine information to patients/carers/relatives as part of the discharge-planning process
  • 5. 21/11/2016 5 Case study - Elsie 78 • Recently discharged from hospital after a fall • She lives alone • Elsie says her mobility and eye sight are getting worse. • Takes Furosemide 40mg BD –doesn’t like ‘water tablet’ • Recently prescribed Nitrazepam to help poor sleep. • Reports feeling thirsty What Are The Risk Factors? • Age • Falls history • Adherence concerns-cognitive/physical • New medication • Undiagnosed disease? • Isolation Supporting Medicines Optimisation & reduce further falls • Is diuretic suitable? Consider recommending an alternative • Switch to a shorter acting benzodiazepine e.g. Zopiclone - consider cessation • Increased thirst may suggests undiagnosed diabetes-referral • Is Elsie managing to take her tablets OK on her own?- Ask the patient-check her medicines with her-advise on correct use - consider compliance aid • Wider question over independence : Engage with MDT/arrange care package
  • 6. 21/11/2016 6 Case Study : Omega 3 Low Priority Poor Value The NHS Midlands and East spent £2.5 million on omega-3 fatty acids compounds in 2012-2013 Source: PrescQIPP Bulletin 47 October 2013 NICE Guideline-Evidence base PrescQIPP Drop List Letter of Advice/PIL to Patient Agree protocol/process Audit practice/patients Monitor savings - summary report Omacor I capsule daily = 28 day saving of £14.28 Medicine Stopped Pharmacist CCG Medicines Review Optimisation
  • 7. 21/11/2016 7 •Prioritise: • Engage the patient in the process •Aim: • Keep regimes as simple as possible-reduce pill burden •Modify: • Make recommendations including cessation- “is the drug still needed?” •Prevent : • Adherence issues-check patient understanding, Identify & resolve barriers, explain & monitor changes Presentation Summary

Editor's Notes

  1. Helping care home rehabilitation staff with medicines management
  2. Rivastigmine Patch Switch where appropriate to capsules-cost saving
  3. Step one: Agree protocol Step two: Patient identification and data collection Step three: Exclusion criteria – patients NOT suitable/eligible for stopping prescribing of omega-3 fatty acid compounds Step four: Stop prescription for omega-3 fatty acid compounds in reviewed patients Step five: Summary report to GP practice Step six: Follow up